DataMEDS AI, Inc.
MEDS
$1.00
$0.033.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.78M | 1.56M | 1.67M | 3.01M | 7.79M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.78M | 1.56M | 1.67M | 3.01M | 7.79M |
| Cost of Revenue | 1.60M | 1.39M | 9.53M | 2.78M | 7.29M |
| Gross Profit | 182.20K | 170.20K | -7.86M | 231.00K | 505.80K |
| SG&A Expenses | 7.17M | 5.83M | 4.14M | 30.98M | 5.20M |
| Depreciation & Amortization | 356.60K | 356.80K | 802.60K | 802.80K | 802.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.12M | 7.58M | 14.47M | 34.56M | 13.29M |
| Operating Income | -7.35M | -6.02M | -12.80M | -31.55M | -5.50M |
| Income Before Tax | -18.36M | -7.74M | -27.85M | -34.32M | -6.67M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -18.36M | -7.74M | -27.85M | -34.32M | -6.67M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.36M | -7.74M | -27.85M | -34.32M | -6.67M |
| EBIT | -7.35M | -6.02M | -12.80M | -31.55M | -5.50M |
| EBITDA | -6.99M | -5.66M | -12.00M | -30.75M | -4.70M |
| EPS Basic | -7.13 | -3.70 | -14.42 | -23.07 | -5.40 |
| Normalized Basic EPS | -2.22 | -2.39 | -4.42 | -13.85 | -3.38 |
| EPS Diluted | -7.13 | -3.70 | -14.42 | -23.07 | -5.40 |
| Normalized Diluted EPS | -2.22 | -2.39 | -4.42 | -13.85 | -3.38 |
| Average Basic Shares Outstanding | 2.57M | 2.09M | 1.93M | 1.49M | 1.24M |
| Average Diluted Shares Outstanding | 2.57M | 2.09M | 1.93M | 1.49M | 1.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |